ArticleMolecular metabolism2024

The GLP-1 medicines semaglutide and tirzepatide do not alter disease-related pathology, behaviour or cognitive function in 5XFAD and APP/PS1 mice.

Leticia Forny Germano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.